GROWTH HORMONE DEFICIENCY IN ADULTS WITH THALASSEMIA: AN OVERVIEW AND THE I-CET RECOMMENDATIONS

01 September 2013

Soliman A, De Sanctis V, Elsedfy H, Yassin M, Skordis N, Karimi M, Sobti P, Raiola G, El Kholy M.

Department of Pediatrics, Division of Endocrinology, Hamad General Hospital Doha, Qatar; Pediatric, Endocrinology and Adolescent Outpatient Clinic, Quisisana Hospital, Ferrara, Italy; Department of Pediatrics, Ain Shams University, Cairo, Egypt; Department of Paediatrics, Division of Pediatric Endocrinology, Makarios Hospital, Nicosia, Cyprus; Department of Hematology, Alamal Hospital, Hamad Medical Center, Doha, Qatar; Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran; Department of Pediatrics, Dayanand Medical College, Ludhiana, Punjab, India; Department of Pediatrics, Pugliese-Ciaccio Hospital, Catanzaro, Italy.

Abstract

This review paper provides a summary of the current state of knowledge regarding GHD provides recommendations for the diagnosis and treatment of GHD in adult patients with thalassaemia major (TM). The reported prevalence of adult GHD and /or IGF-I deficiency in TM patients varies from 8% to 44 % in different centers. Because GH treatment requires analysis of many factors, including the effect of treatment on cardiac functions, metabolic parameters and psychosocial functioning, along with safety, ethical considerations, financial cost and other burdens of therapy, stringent diagnostic criteria are needed.

The authors report the diagnostic recommendations of the International Study Group of Endocrine Complications in Thalassemia (I-CET) for adult TM patients. The pros and cons of GH treatment must be discussed with each patient, after which GH doses should be individualized and titrated to maximum efficacy with minimal side effects.

Prospective studies to monitor potential benefits versus possible side-effects will enable endocrinologists to define recommendations on dosage and the long term effects, particularly on cardiovascular and bone status of GH therapy in adult TM patients.

Pub Med

Source: http://www.ncbi.nlm.nih.gov/pubmed/24099819

GROWTH HORMONE DEFICIENCY IN ADULTS WITH THALASSEMIA: AN OVERVIEW AND THE I-CET RECOMMENDATIONS

Categories

Last posts

Casa di Cura Quisisana entered in ...

Initial Clinical Evaluation

Neurally mediated syncope starting ...

Regional Congress A.R.C.A. ...

Other posts from the same category

Neurally mediated syncope starting in old age does not appear to be unique to humans: new perspective

Initial Clinical Evaluation

THE EQUALITY PROJECT

EQUALITY PROJECT, THE FOURTH MAGAZINE

NEW ARTICLE BY DR. ALBONI ON THE HEART MAGAZINE

EQUALITY PROJECT, THE THIRD MAGAZINE

PROJECT EQUALITY, THE FIRST MAGAZINE

EQUALITY PROJECT, THE SECOND MAGAZINE

NEW PUBLICATION BY DR. ALBONI P. AND ALBONI M.

NEW ARTICLE PROF. ALBONI ON THE ITALIAN CARDIOLOGY JOURNAL

NEW SCIENTIFIC PUBLICATION BY DR. ALBONI

NEW PUBLICATION BY DR. ALBONI ON THE ITALIAN CARDIOLOGY JOURNAL

Book your visit online